| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA326925
Max Phase: Preclinical
Molecular Formula: C18H19N7O
Molecular Weight: 349.40
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COCC/N=N/Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1
Standard InChI: InChI=1S/C18H19N7O/c1-26-11-10-21-25-24-16-6-2-5-15(12-16)22-18-20-9-7-17(23-18)14-4-3-8-19-13-14/h2-9,12-13H,10-11H2,1H3,(H,21,24)(H,20,22,23)
Standard InChI Key: GPNNPQVERGYRNV-UHFFFAOYSA-N
Associated Targets(Human)
Tyrosine-protein kinase ABL 162 Activities
K562 73714 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 349.40 | Molecular Weight (Monoisotopic): 349.1651 | AlogP: 3.71 | #Rotatable Bonds: 8 |
| Polar Surface Area: 96.68 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.18 | CX Basic pKa: 4.26 | CX LogP: 2.79 | CX LogD: 2.79 |
| Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.37 | Np Likeness Score: -1.28 |
References
| 1. Rachid Z, Katsoulas A, Brahimi F, Jean-Claude BJ.. (2003) Synthesis of pyrimidinopyridine-triazene conjugates targeted to abl tyrosine kinase., 13 (19): [PMID:12951113] [10.1016/s0960-894x(03)00553-5] |
Source
Source(1):